INVEGA TRINZA (Janssen Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the INVEGA TRINZA drug offered from Janssen Pharmaceuticals, Inc. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc |
| NON-PROPRIETARY NAME: | paliperidone palmitate |
| SUBSTANCE NAME: | PALIPERIDONE PALMITATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-05-19 |
| END MARKETING DATE: | 0000-00-00 |
INVEGA TRINZA HUMAN PRESCRIPTION DRUG Details:
| Item Description | INVEGA TRINZA from Janssen Pharmaceuticals, Inc |
| LABELER NAME: | Janssen Pharmaceuticals, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 273(mg/.875mL) |
| START MARKETING DATE: | 2015-05-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50458-606_cee057fd-9f3d-43d0-8779-0230b0d187c1 |
| PRODUCT NDC: | 50458-606 |
| APPLICATION NUMBER: | NDA207946 |
Other PALIPERIDONE PALMITATE Pharmaceutical Manufacturers / Labelers:
